Antibodies may predict transplant rejection risk

June 19, 2018 by Anna Williams, Northwestern University
Credit: CC0 Public Domain

The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

"The field of transplantation will benefit from this study by being able to better determine the risk of in some ," said co-author John Friedewald, MD, professor of Medicine in the Division of Nephrology and Hypertension and of Surgery in the Division of Organ Transplantation.

Despite immunosuppressive therapies, organ rejection remains a significant challenge in transplantation, with thousands of transplanted organs failing each year.

In previous studies, a group of antibodies called anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) have been increasingly recognized as an important contributor to rejection and long-term failure of transplanted organs, especially of kidneys. However, it has remained unclear whether anti-HLA DSAs are associated with poor outcomes in transplantation consistently across patient populations, and across multiple organ types.

In the current study, investigators performed a meta-analysis of 37 publications, which included data from close to 8,000 patients who had received either kidney, liver, heart or lung transplants.

The scientists discovered that organ recipients with circulating complement-activating anti-HLA DSAs had a three-fold increased risk of long-term loss—compared to patients without anti-HLA DSAs or with those anti-HLA DSAs that were considered non-complement-activating. Beyond survival, the antibodies were also associated with an increased risk of organ rejection.

The findings were consistent across all organ types and across different tests and times of evaluation.

Overall, the results suggest that complement-activating anti-HLA DSAs could potentially serve as a biomarker to stratify the risk of and failure in transplant patients.

"The clinical implication will be better donor selection and improved monitoring for people needing a transplant and after transplant," Friedewald said.

The authors also note that further research is needed in order to investigate whether the antibodies might also represent a route to therapeutics interventions. "Eventually, this could lead to improved treatment protocols for rejection," Friedewald said.

Explore further: Transplanted livers help body defend against organ rejection, study finds

More information: Antoine Bouquegneau et al. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis, PLOS Medicine (2018). DOI: 10.1371/journal.pmed.1002572

Related Stories

Transplanted livers help body defend against organ rejection, study finds

April 18, 2018
For decades, transplant experts have observed that liver transplant recipients often need less anti-rejection medication, known as immunosuppressive drugs, than recipients of other solid organs. Similarly, when patients receive ...

Timing of anti-donor antibody responses affects the survival of kidney transplants

March 2, 2017
New research provides insights on transplant recipients' antibody responses against donor kidneys and how the timing of those responses can have important implications. The findings appear in an upcoming issue of the Journal ...

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Understanding immune system interplay to improve organ transplant success

May 31, 2018
A rare opportunity to analyse both blood and tissue samples from human transplant recipients has allowed immunology researchers at the Babraham Institute to pinpoint how an immunosuppressive drug works to prevent the production ...

Promising breakthrough for transplant patients

February 27, 2013
A team led by Dr. Marie-Josée Hébert from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class ...

Antibodies in the blood provide clues to transplant recipients' likelihood of rejection

August 20, 2015
The dominant antibody type present in the blood of transplant recipients may indicate their likelihood of experiencing organ rejection, according to a study appearing in an upcoming issue of the Journal of the American Society ...

Recommended for you

Surgeons have substantial impact on genetic testing in breast cancer patients who need it

July 3, 2018
For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. But studies have shown that only about half of women who could benefit receive genetic testing.

First major study comparing robotic to open surgery published in The Lancet

June 21, 2018
The first comprehensive study comparing the outcomes of robotic surgery to those of traditional open surgery in any organ has found that the surgeries are equally effective in treating bladder cancer. The seven-year study, ...

Antibodies may predict transplant rejection risk

June 19, 2018
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

First human test of robotic eye surgery a success

June 18, 2018
Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.

Surgical blood transfusions tied to clot risk

June 13, 2018
(HealthDay)—Blood transfusions around the time of surgery may raise your risk for dangerous blood clots, researchers say.

Tonsil and adenoid removal associated with respiratory, allergic and infectious disease

June 7, 2018
Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.